Inhibition of cell death responses induced by oxidative stress

Details for Australian Patent Application No. 2003226209 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Kufe, Donald W; Kaddurah-Daouk, Rima

Agent Davies Collison Cave

Pub. Number AU-B-2003226209

PCT Number PCT/US03/10112

PCT Pub. Number WO2003/080061

Priority 60/366,410 21.03.02 US

Filing date 20 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 23 October 2008

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/366,410 21.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003226209

23 October 2008 Application Accepted

  Published as AU-B-2003226209

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226210-GUTTER PUNCH

2003226208-POLYNUCLEOTIDE PRIMERS AND PROBES FOR RAPID DETECTION OF GROUP B STREPTOCOCCUS (GBS)